Effect of Adding Personalized Instant Messaging Apps to a Brief Smoking Cessation Model in Community Smokers in Hong Kong: Pragmatic Randomized Clinical Trial
Journal of Medical Internet Research · 2024
DOI: 10.2196/44973 ↗Kurz gefasst
Pragmatische Studie in der Zeitschrift Journal of Medical Internet Research, 2024. Verfasst von Yongda Socrates Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, The University of Hong Kong, Hong Kong, China (Hong Kong). Hauptthemen laut MEDLINE: Mobile Applications, Smoking Cessation, Text Messaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
While text messaging has proven effective for smoking cessation (SC), engagement in the intervention remains suboptimal.
Objective
This study aims to evaluate whether using more interactive and adaptive instant messaging (IM) apps on smartphones, which enable personalization and chatting with SC advisors, can enhance SC outcomes beyond the provision of brief SC advice and active referral (AR) to SC services.
Methods
From December 2018 to November 2019, we proactively recruited 700 adult Chinese daily cigarette users in Hong Kong. Participants were randomized in a 1:1 ratio. At baseline, all participants received face-to-face brief advice on SC. Additionally, they were introduced to local SC services and assisted in selecting one. The intervention group received an additional 26 personalized regular messages and access to interactive chatting through IM apps for 3 months. The regular messages aimed to enhance self-efficacy, social support, and behavioral capacity for quitting, as well as to clarify outcome expectations related to cessation. We developed 3 sets of messages tailored to the planned quit date (within 30 days, 60 days, and undecided). Participants in the intervention group could initiate chatting with SC advisors on IM themselves or through prompts from regular messages or proactive inquiries from SC advisors. The control group received 26 SMS text messages focusing on general health. The primary outcomes were smoking abstinence validated by carbon monoxide levels of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, The University of Hong Kong, Hong Kong, China (Hong Kong).
- Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
- Department of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong, China (Hong Kong).
- School of Public Health, The University of Hong Kong, Hong Kong, China (Hong Kong).
- Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong).
ORCID-Profile: Yongda Socrates Wu, Yee Tak Derek Cheung, Jay Jung Jae Lee, Carlos King Ho Wong, Sai Yin Ho, William Ho Cheung Li, Ying Yao, Tai Hing Lam, Man Ping Wang
Zitieren
APA
Wu, Y. S., Cheung, Y. T. D., Lee, J. J. J., Wong, C. K. H., Ho, S. Y., Li, W. H. C., Yao, Y., Lam, T. H., & Wang, M. P. (2024). Effect of Adding Personalized Instant Messaging Apps to a Brief Smoking Cessation Model in Community Smokers in Hong Kong: Pragmatic Randomized Clinical Trial. Journal of Medical Internet Research. https://doi.org/10.2196/44973
Vancouver
Wu YS, Cheung YTD, Lee JJJ, Wong CKH, Ho SY, Li WHC, et al. Effect of Adding Personalized Instant Messaging Apps to a Brief Smoking Cessation Model in Community Smokers in Hong Kong: Pragmatic Randomized Clinical Trial. Journal of Medical Internet Research. 2024. doi:10.2196/44973
BibTeX
@article{Wu2024,
author = {Wu, Yongda Socrates and Cheung, Yee Tak Derek and Lee, Jay Jung Jae and Wong, Carlos King Ho and Ho, Sai Yin and Li, William Ho Cheung and Yao, Ying and Lam, Tai Hing and Wang, Man Ping},
title = {Effect of Adding Personalized Instant Messaging Apps to a Brief Smoking Cessation Model in Community Smokers in Hong Kong: Pragmatic Randomized Clinical Trial},
journal = {Journal of Medical Internet Research},
year = {2024},
doi = {10.2196/44973}
}
EUVIMED